The possible influence of pulmonary arterio-venous shunt and hypoxic pulmonary vasoconstriction on arterial sevoflurane concentration during one-lung ventilation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21081765.
- Also identified by DOI 10.1213/ANE.0b013e3182025c8e.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sevoflurane is widely used for its rapid onset and offset due to a lower blood/gas coefficient. However, involuntary movements, tachycardia, and hypertension have been observed in some patients despite a continuing constantly delivered concentration of sevoflurane during 1-lung ventilation (OLV), indicating the possibility of insufficient depth of anesthesia. We observed a temporary but obvious decrease in arterial sevoflurane concentration and pulse oximeter readings in a patient during OLV. This may have resulted in the depth of inhaled anesthesia being insufficient during OLV because the arterial sevoflurane concentration was lower than expected in spite of constantly delivered and inspiratory/expiratory sevoflurane concentrations.
Medical subject headings
- Anesthetics, Inhalation
- Hypoxia
- Lung
- Methyl Ethers
- Pulmonary Artery
- Pulmonary Circulation
- Pulmonary Veins
- Respiration, Artificial
- Vasoconstriction